Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions

Samuel Cos1, Alicia González, Carlos Martínez-Campa

  • 1Department of Physiology and Pharmacology, School of Medicine, University of Cantabria, 39011 Santander, Spain. coss@unican.es

Abstract

Insights

Melatonin shows oncostatic effects against breast cancer by reducing estrogen signaling. It acts both indirectly by lowering estrogen levels and directly by interfering with estrogen receptors and synthesis.

Area of Science:

  • Endocrinology
  • Oncology
  • Pharmacology

Background:

  • Melatonin demonstrates oncostatic properties against various tumors, particularly endocrine-responsive breast cancer.
  • Studies indicate melatonin reduces mammary tumor incidence and growth in vivo, and inhibits breast cancer cell proliferation and metastasis in vitro.
  • These effects are primarily attributed to melatonin's anti-estrogenic actions on hormone-dependent mammary tumors.

Purpose of the Study:

  • To elucidate the mechanisms by which melatonin reduces breast cancer development through its interaction with estrogen-signaling pathways.
  • To explore both indirect neuroendocrine and direct cellular mechanisms of melatonin's oncostatic effects.

Main Methods:

  • Investigated indirect mechanisms involving melatonin's down-regulation of the hypothalamic-pituitary reproductive axis, leading to reduced circulating estrogen levels.
  • Examined direct cellular mechanisms, including melatonin's interference with estrogen receptor activation (acting as a selective estrogen receptor modulator).
  • Assessed melatonin's regulation of aromatase activity, impacting local estrogen synthesis (acting as a selective estrogen enzyme modulator).

Main Results:

  • Melatonin effectively reduces circulating estrogen levels via indirect neuroendocrine pathways.
  • Melatonin directly inhibits estrogen receptor activation in mammary tumor cells.
  • Melatonin modulates aromatase activity, decreasing local estrogen biosynthesis.

Conclusions:

  • Melatonin possesses dual properties to counteract estrogen effects on breast tissue and inhibit local estrogen biosynthesis.
  • These mechanisms position melatonin as a promising anticancer agent for preventing and treating estrogen-dependent tumors.
  • Melatonin's ability to target multiple levels of estrogen-signaling pathways enhances its therapeutic potential.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...